Clinical Trial Update: Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for consolidation immunotherapy in acute lymphoblastic leukemia patients who are unfit or decline chemotherapy; the regimens invol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)
• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Lymphoblastic Leukemia, Immunotherapy | Phase 2 | Status: RECRUITING